Thomson Reuters (TRI - Free Report) , a Zacks Rank #5 (Strong Sell), is a leading provider of value-added information and technology to users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare.
Recent Earnings Data
In its Q1 18 earnings report, TRI missed the Zacks consensus earnings estimate, but beat the revenue estimate. On a year over year basis earnings fell by -55.6%, and revenues declined by -51%. The company had previously announced that they will be selling a 55% stake of its Financial and Risk business to Blackstone for $17 billion. It is currently expected that management will used some of the proceeds for share buybacks.
Management’s Take
According to Jim Smith, President and CEO, “We are encouraged by the best first-quarter performance in several years with each business having performed at or above our expectations. The health of our Q1 results gives us even greater conviction in our ability to stay focused on the opportunities at hand, while simultaneously working quickly to close the proposed F&R/Blackstone partnership and prepare both companies for future success. We are excited about the potential to further strengthen our Legal and Tax businesses -- both organically and inorganically, with the financial wherewithal and flexibility to deliver for our customers and shareholders.”
Looking Forward
While the long term outlook for TRI is positive, the transition period over the next few years due to the sale of its Financial & Risk business has caused earnings estimates to be trimmed by several coverage analysts. Further, management significantly increased its corporate expense estimates due to stranded costs and investments; currently expected to be between $500-600 million. The completion of the deal is expected to be on 9-30-18, so these expenses could change. Further, if there is a delay on the closure of the deal, the stock repurchase program could be pushed out further than expected.
Price and Earnings Consensus Graph
As you can see in the graph below, the stock price and future earnings estimates have been falling for most of 2018.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Thomson Reuters (TRI - Free Report) , a Zacks Rank #5 (Strong Sell), is a leading provider of value-added information and technology to users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare.
Recent Earnings Data
In its Q1 18 earnings report, TRI missed the Zacks consensus earnings estimate, but beat the revenue estimate. On a year over year basis earnings fell by -55.6%, and revenues declined by -51%. The company had previously announced that they will be selling a 55% stake of its Financial and Risk business to Blackstone for $17 billion. It is currently expected that management will used some of the proceeds for share buybacks.
Management’s Take
According to Jim Smith, President and CEO, “We are encouraged by the best first-quarter performance in several years with each business having performed at or above our expectations. The health of our Q1 results gives us even greater conviction in our ability to stay focused on the opportunities at hand, while simultaneously working quickly to close the proposed F&R/Blackstone partnership and prepare both companies for future success. We are excited about the potential to further strengthen our Legal and Tax businesses -- both organically and inorganically, with the financial wherewithal and flexibility to deliver for our customers and shareholders.”
Looking Forward
While the long term outlook for TRI is positive, the transition period over the next few years due to the sale of its Financial & Risk business has caused earnings estimates to be trimmed by several coverage analysts. Further, management significantly increased its corporate expense estimates due to stranded costs and investments; currently expected to be between $500-600 million. The completion of the deal is expected to be on 9-30-18, so these expenses could change. Further, if there is a delay on the closure of the deal, the stock repurchase program could be pushed out further than expected.
Price and Earnings Consensus Graph
As you can see in the graph below, the stock price and future earnings estimates have been falling for most of 2018.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on TRI - FREE